Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice

被引：0
|
作者：
T. Thomas
S. Horlait
J. D. Ringe
A. Abelson
D. T. Gold
P. Atlan
J. L. Lange
机构：
[1] University Hospital of Saint-Etienne,INSERM U1059, Rheumatology Department
[2] Warner Chilcott,Medizinische Klinik IV (Osteology, Rheumatology), Klinikum Leverkusen
[3] University of Cologne,undefined
[4] Cleveland Clinic Foundation,undefined
[5] Duke University Medical Center,undefined
[6] Procter & Gamble,undefined
来源：
Osteoporosis International | 2013年 / 24卷
关键词：
Bisphosphonates; Clinical fractures; Glucocorticoid-induced osteoporosis; Risk reduction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：263 / 269
页数：6
相关论文
共 50 条
  • [1] Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice
    Thomas, T.
    Horlait, S.
    Ringe, J. D.
    Abelson, A.
    Gold, D. T.
    Atlan, P.
    Lange, J. L.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (01) : 263 - 269
  • [2] Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice
    Adami, Giovanni
    Rahn, Elizabeth J.
    Saag, Kenneth G.
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2019, 11
  • [3] The prevention and treatment of glucocorticoid-induced osteoporosis in clinical practice
    Walker-Bone, K
    Wood, A
    Hull, R
    Ledingham, JM
    McCrae, FC
    Shaban, R
    Thomas, A
    Mackay, K
    CLINICAL MEDICINE, 2004, 4 (05) : 431 - 436
  • [4] Bisphosphonates and glucocorticoid-induced osteoporosis: cons
    Willem F. Lems
    Kenneth Saag
    Endocrine, 2015, 49 : 628 - 634
  • [5] Bisphosphonates and glucocorticoid-induced osteoporosis: cons
    Lems, Willem F.
    Saag, Kenneth
    ENDOCRINE, 2015, 49 (03) : 628 - 634
  • [6] Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis
    Blair, MM
    Carson, DS
    Barrington, R
    JOURNAL OF FAMILY PRACTICE, 2000, 49 (09) : 839 - 848
  • [7] Bisphosphonates and glucocorticoid-induced osteoporosis: Efficacy and tolerability
    Lespessailles, Eric
    JOINT BONE SPINE, 2013, 80 (03) : 258 - 264
  • [8] Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis
    Roux, C
    Dougados, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (05) : S49 - S52
  • [9] Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
    Chuanjian Yuan
    Yanchen Liang
    Kai Zhu
    Wenpeng Xie
    Journal of Orthopaedic Surgery and Research, 18
  • [10] Glucocorticoid-induced osteoporosis: Clinical and therapeutic aspects
    Mazziotti, Gherardo
    Giustina, Andrea
    Canalis, Ernesto
    Bilezikian, John P.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (08) : 1404 - 1412
12345